← All trials
NCT07268170
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 15, 2025
- Primary completion
- Sep 1, 2028
- Completion date
- Sep 30, 2028
- First posted
- Dec 5, 2025
- Last posted
- Dec 17, 2025
- Enrollment
- 350
- Arms / groups
- 9 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Gødstrup HospitalLead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.